After the transaction, 667, L.P's stake was reported as 9,822,003 shares of Genomic Health Inc stock.
As noted on November 14, 2012, 667, L.P's purchase was done indirectly through "See Footnote" over 24 transactions from November 9, 2012 to November 13, 2012. The share price ranged from $25.83 to $27.99 according to the regulatory filing detailing the transactions.
If we look over the past 12 months, 667, L.P has sold no shares of Genomic Health Inc stock. Over the same time period, 667, L.P has purchased 823,772 shares of Genomic Health Inc, with a total cost of $22,908,326.
Let's take a quick, high-level look at insider trading at Genomic Health Inc over the past 12 months. A total of 453,899 shares of Genomic Health Inc stock was sold by insiders, totaling $13,997,341. Over the same time 12 month time period, 3,686,440 shares of Genomic Health Inc, for a total value of $106,410,117 were purchased by company insiders.
To view the complete SEC Filing: Genomic Health Inc Form 4 (Insider Trading) SEC Filing
